InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（11 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
11
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Geffner Michael, Chief Medical Officer. Director active across 1 company, notably Immunovant, Inc.. Cumulatively, 13 disclosures have been logged. Breakdown: 0 buy · 11 sells. Total volume traded: €890k. History available since 26 January 2024. The latest transaction was disclosed on 22 October 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Geffner Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
2,595 股@ US$19.030.0008% mcap27.5% 占其流量Common StockSEC:0001764013-25-000144:0
1,272 股@ US$16.300.0003% mcap11.5% 占其流量Common StockSEC:0001764013-25-000140:0
2,385 股@ US$18.154.1% 占其流量Common StockSEC:0001764013-25-000114:0
1,160 股@ US$17.240.0003% mcap11.0% 占其流量Common StockSEC:0001764013-25-000109:0
2,349 股@ US$14.793.3% 占其流量Common StockSEC:0001764013-25-000082:0
6,169 股@ US$12.997.9% 占其流量Common StockSEC:0001764013-25-000068:0
101,574 股0Common StockSEC:0001764013-25-000053:0
2,657 股@ US$23.596.5% 占其流量Common StockSEC:0001764013-25-000018:0
3,189 股@ US$29.539.4% 占其流量Common StockSEC:0001764013-24-000179:0
3,456 股@ US$27.769.5% 占其流量Common StockSEC:0001764013-24-000142:0
3,261 股@ US$28.909.5% 占其流量Common StockSEC:0001764013-24-000089:0
54,978 股0Common StockSEC:0001764013-24-000050:0
9,948 股@ US$37.9137.4% 占其流量Common StockSEC:0001764013-24-000017:0
13 条申报中的 13 条
About Geffner Michael
Michael Geffner serves as Chief Medical Officer at Immunovant, Inc. In this role, he is responsible for leading the company's medical and clinical initiatives, ensuring that products and services meet health and safety standards. His medical expertise is essential for the development of innovative treatments.
